Invention Grant
US08669232B2 Flavonol compounds, a bioactive extract/fraction from Ulmus wallichiana and its compounds for prevention for treatment of osteo-health related disorders
有权
黄酮醇化合物,来自榆树的生物活性提取物/部分及其用于治疗骨骼健康相关疾病的化合物
- Patent Title: Flavonol compounds, a bioactive extract/fraction from Ulmus wallichiana and its compounds for prevention for treatment of osteo-health related disorders
- Patent Title (中): 黄酮醇化合物,来自榆树的生物活性提取物/部分及其用于治疗骨骼健康相关疾病的化合物
-
Application No.: US12920927Application Date: 2009-03-03
-
Publication No.: US08669232B2Publication Date: 2014-03-11
- Inventor: Rakesh Maurya , Preeti Rawat , Kunal Sharan , Jawed Akhtar Siddiqui , Gaurav Swarnkar , Geetanjali Mishra , Lakshmi Manickavasagam , Girish Kumar Jain , Kamal Ram Arya , Naibedya Chattopadhyay
- Applicant: Rakesh Maurya , Preeti Rawat , Kunal Sharan , Jawed Akhtar Siddiqui , Gaurav Swarnkar , Geetanjali Mishra , Lakshmi Manickavasagam , Girish Kumar Jain , Kamal Ram Arya , Naibedya Chattopadhyay
- Applicant Address: IN New Delhi
- Assignee: Council of Scientific & Industrial Research
- Current Assignee: Council of Scientific & Industrial Research
- Current Assignee Address: IN New Delhi
- Agency: Ladas & Parry LLP
- Priority: IN534/DEL/2008 20080305
- International Application: PCT/IN2009/000146 WO 20090303
- International Announcement: WO2009/110003 WO 20090911
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K31/7028 ; A61K31/7042 ; C07H1/08

Abstract:
The present invention provides a flavonol compound and a bioactive extract/fraction from Ulmus wallichiana useful for the management or prevention or treatment of bone disorders. Said extract/fraction comprising marker compounds of general formula 2, K058: R1═R2═OH K012: R1═R2═OH, 2,3 double bond K068: R1═R2═H KIOOi R1═OH, R2═H mula 2 Wherein the marker compounds K012, K058, K068, K1OO ranges 6.7-12%, 1.7-4.5%, 0.6-1.2%, 1.7-4.5% respectively in alcoholic extract and a process of extraction thereof. According to another aspect of the invention provides a pharmaceutical composition comprising the said compound. The present invention further provides a method of treating bone disorders by administering the pharmaceutical composition by oral, intravenous, subcutaneous, intra-peritoneal or intramuscular route.
Public/Granted literature
Information query